PMID: 11929691Apr 4, 2002Paper

Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99)

Diagnostic Microbiology and Infectious Disease
Jan M BellSentry APAC Study Group

Abstract

The frequency of occurrence of ESBL-producing clinical strains varies widely in distinct geographic areas. The objective of this study was to describe the frequency of occurrence, the preferred substrate, and the co-resistance patterns of the ESBL-producing isolates collected from the Asia-Pacific region and South Africa through the SENTRY Antimicrobial Surveillance Program between January 1998 and December 1999. A total of 1,377 Escherichia coli, 678 Klebsiella pneumoniae, and 138 Proteus mirabilis isolates were collected from diverse body sites. Using NCCLS criteria, 139 E. coli (10.1%), 171 K. pneumoniae (25.2%), and 2 P. mirabilis (1.4%) had presumptive ESBL phenotypes; 100, 146 and 1 strain respectively were confirmed to be ESBL producers on clavulanate enhancement testing. The frequency of occurrence of confirmed ESBL-producing E. coli by the medical centers varied from 0-1% for centers located in Australia to 13-35% for mainland Chinese centers. The higher prevalence rates (>20%) of ESBL K. pneumoniae phenotypes were observed in all mainland Chinese centers, one Japanese and one Taiwanese center, and in the Philippine, South African, Singaporean and medical centers. The spread of the presumptive ESBL phenotype to the Ent...Continue Reading

References

May 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C C Sanders
Sep 1, 1991·Antimicrobial Agents and Chemotherapy·G A Jacoby, A A Medeiros
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·A PhilipponG Jacoby
Sep 1, 1989·Infection·A PhilipponA Ben Hassen
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Jan 1, 1995·The Journal of Antimicrobial Chemotherapy·P J JenksD M Livermore
Jan 9, 1998·Infectious Disease Clinics of North America·G A Jacoby
Oct 19, 2000·Antimicrobial Agents and Chemotherapy·R BonnetJ Sirot
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P L WinokurN Legakis

❮ Previous
Next ❯

Citations

Oct 14, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·O T KatzP Yagupsky
Oct 16, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E S LestariUNKNOWN Antimicrobial Resistance in Indonesia: Prevalence and Prevention (AMRIN)
Jun 26, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A GündoğduM Katouli
Jan 29, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E MontassierM F de La Cochetière
Mar 17, 2004·Diagnostic Microbiology and Infectious Disease·Tsai-Ling LauderdaleUNKNOWN TSAR Participating Hospitals
Jul 14, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Reuben Ramphal
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L PatersonVictor L Yu
Mar 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael A Pfaller, John Segreti
Mar 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Reuben Ramphal, Paul G Ambrose
Feb 2, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Umaer Naseer, Arnfinn Sundsfjord
Aug 15, 2012·Antimicrobial Agents and Chemotherapy·Jennifer H HanEbbing Lautenbach
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Tersia KrugerDavid L Paterson
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·J R HernándezUNKNOWN Spanish Group for Nosocomial Infections (GEIH)
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Mitchell J SchwaberYehuda Carmeli
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Deverick J AndersonKeith S Kaye
Oct 15, 2005·Clinical Microbiology Reviews·David L Paterson, Robert A Bonomo
Dec 7, 2007·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Mansour Al-ZarouniDebadatta Panigrahi
Sep 3, 2011·Journal of Global Infectious Diseases·Olusolabomi J IdowuGbolahan O Babalola
Sep 17, 2013·The Journal of Antimicrobial Chemotherapy·Michael G HeadNeil Woodford
Mar 6, 2012·International Journal of Antimicrobial Agents·David M Livermore
Jul 19, 2011·Critical Care Research and Practice·Rishi H-P Dhillon, John Clark
Mar 15, 2011·Diagnostic Microbiology and Infectious Disease·Gisele PeiranoJohann D D Pitout
Oct 22, 2005·International Journal of Medical Microbiology : IJMM·Heike von Baum, Reinhard Marre
Jul 13, 2004·Diagnostic Microbiology and Infectious Disease·Maria Virginia VillegasUNKNOWN Colombian Nosocomial Resistance Study Group (See )
Oct 16, 2004·Expert Review of Anti-infective Therapy·Thomas D Gootz
Mar 3, 2006·The Journal of Antimicrobial Chemotherapy·Giuseppe CelenzaMariagrazia Perilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

© 2022 Meta ULC. All rights reserved